By clicking ‘Do I Qualify’ and submitting my request, I provide my electronic signature and consent to receive phone calls and/or text message from Total Injury Help to the above telephone number containing offers to identify a lawyer in its network that may assist me. These communications may be generated using an autodialer, and/or pre-recorded or artificial voice, and that consent is not required to utilize Total Injury Help services. This authorization overrides any previous registrations on a federal or state Do Not Call registry. I agree to the privacy policy and terms (including mandatory arbitration and class waiver).
ATTENTION:
If You Have Cancer and Took Zantac for Heartburn, You May be Entitled to Significant Compensation
- • The FDA issued a recall on Zantac because of high levels of the probable human carcinogen Nitrosodimethylamine (NDMA)
- • Zantac failed to notify the public of this chemical in their product, choosing to gain profit rather than keep consumers safe
Find Out If You Qualify
SIGNIFICANT Compensation May Be Available
- • The FDA issued a recall on Zantac because of high levels of the probable human carcinogen Nitrosodimethylamine (NDMA)
- • Zantac failed to notify the public of this chemical in their product, choosing to gain profit rather than keep consumers safe
As Seen On:
FDA Removes Zantac From Shelves Over Probable Human Carcinogen NDMA
FDA Removes Zantac From Shelves Over Probable Human Carcinogen NDMA
In April of 2020, the FDA determined that Zantac posed a risk to public health due to high amounts of the chemical NDMA. NDMA is a chemical used to make rocket fuel, as well as purposely induce cancer in lab animals for medical studies. NDMA is considered a probable human carcinogen by both the World Health Organization (WHO), and the U.S. Environmental Protection Agency (EPA).
The FDA permits a daily intake of 96 nanograms of NDMA, but testing revealed each tablet contained over 3,000,000 nanograms. That’s 3,000 times greater than the FDA’s intake limit.
The makers of Zantac have made billions from the drug, and had information that Zantac contained NDMA as early as 1981. They failed to warn consumers, doctors, or government regulators of the risk, and chose to gain profit rather than keep consumers safe.